Nuria Ribelles Entrena

Title: Nuria Ribelles Entrena: Innovator in Breast Cancer Research

Introduction

Nuria Ribelles Entrena is a prominent inventor based in Seville, Spain. She has made significant contributions to the field of oncology, particularly in the area of breast cancer treatment. Her innovative work focuses on predicting the risk of early recurrence in breast cancer patients.

Latest Patents

Nuria Ribelles Entrena holds a patent titled "Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer." This invention relates to methods for predicting the risk of recurrence of breast tumors by measuring the expression levels of specific microRNAs. The patent outlines a method that involves assessing the expression levels of at least one miRNA from a defined group, which includes miR-149-5p, miR-10a-5p, miR-20b-5p, miR-30a-3p, and miR-342-5p in tumor samples. A change in the expression level of these miRNAs compared to a control sample indicates a high risk of tumor recurrence. Additionally, the invention includes tools and kits designed to facilitate this method.

Career Highlights

Throughout her career, Nuria has worked with notable organizations such as Servicio Andaluz de Salud and Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS). Her work in these institutions has allowed her to advance her research and contribute to the medical community.

Collaborations

Nuria Ribelles Entrena has collaborated with esteemed colleagues, including José Lozano Castro and Emilio Alba Conejo. These partnerships have enriched her research and expanded the impact of her innovations in cancer treatment.

Conclusion

Nuria Ribelles Entrena is a trailblazer in the field of breast cancer research, with her patented methods offering new hope for predicting tumor recurrence. Her contributions to oncology continue to influence the medical landscape and improve patient outcomes.